KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Debt Ratio (2016 - 2025)

Sarepta Therapeutics (SRPT) has 15 years of Debt Ratio data on record, last reported at 0.31 in Q3 2025.

  • For Q3 2025, Debt Ratio fell 10.08% year-over-year to 0.31; the TTM value through Sep 2025 reached 0.31, down 10.08%, while the annual FY2024 figure was 0.29, 24.34% down from the prior year.
  • Debt Ratio reached 0.31 in Q3 2025 per SRPT's latest filing, down from 0.31 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.49 in Q4 2022 and bottomed at 0.29 in Q4 2024.
  • Average Debt Ratio over 5 years is 0.38, with a median of 0.38 recorded in 2023.
  • Peak YoY movement for Debt Ratio: skyrocketed 69.05% in 2021, then decreased 24.34% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.35 in 2021, then soared by 41.67% to 0.49 in 2022, then dropped by 23.18% to 0.38 in 2023, then fell by 24.34% to 0.29 in 2024, then rose by 6.86% to 0.31 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.31 in Q3 2025, 0.31 in Q2 2025, and 0.33 in Q1 2025.